Fundraising Fox

Algen Biotechnologies

YC W20

San Francisco, US · Founded 2018 · 15 employees · 4 known investors

algenbio.com

Algen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesAI-powered Drug DiscoveryArtificial IntelligenceCRISPRin /company@ycombinatorycombinator.com ↗

Founders & leadership· Y Combinator alumni (W20)

JDJennifer Doudna
Jennifer Doudna
DJ
Dr. Jeff WhittenChief Scientific Officer

Investors · 4

In the news